Greek study aims to better measure Hypoparathyroidism's impact

NCT ID NCT07160348

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will translate and test two questionnaires (HPES-Symptom and HPES-Impact) for Greek-speaking adults with chronic hypoparathyroidism. Researchers will enroll 200 patients across several hospitals in Greece. The goal is to ensure the questionnaires accurately capture patients' symptoms and daily-life challenges in Greek, so doctors can use them to improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a reliable tool to measure how hypoparathyroidism affects patients in Greece, helping doctors better understand and manage the condition.

What could go wrong

This is a translation and validation study, not a treatment trial. It won't directly improve patient health, and the questionnaire may not capture all important aspects of the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

calcium metabolic disease hypoparathyroidism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.